Literature DB >> 8478141

N-terminal peptide fragments of lipocortin-1 inhibit A549 cell growth and block EGF-induced stimulation of proliferation.

J D Croxtall1, S Waheed, Q Choudhury, R Anand, R J Flower.   

Abstract

Lipocortin-1 mediates growth inhibition of glucocorticoids in A549 cells by suppressing the release of PGE2 necessary for their proliferation. We now show that 2 peptide fragments derived from the N-terminal portion of lipocortin-1 corresponding to amino-acids 13-25 and 21-33 also inhibited A549 cell growth and suppressed release of PGE2, whereas peptides 1-12 and 13-25 (Phe21; in which the tyrosine at position 21 was replaced by a phenylalanine residue) were inactive. Similarly, peptide 21-33 (Phe21) and a scrambled sequence of 13-25 failed to inhibit cell growth. Moreover, the EGF-induced stimulation of cell proliferation and PGE2 release in these cells was blocked by peptides 13-25 and 21-33, and also by peptides 1-12, 13-25 (Phe21) and 21-33 (Phe21), but not by a scrambled sequence of peptide 13-25.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8478141     DOI: 10.1002/ijc.2910540124

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

1.  Investigation into the involvement of phospholipases A(2) and MAP kinases in modulation of AA release and cell growth in A549 cells.

Authors:  Q G Choudhury; D T McKay; R J Flower; J D Croxtall
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

2.  Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor-dependent, transcription-independent mechanism.

Authors:  J D Croxtall; Q Choudhury; R J Flower
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

3.  Lack of annexin 1 results in an increase in corticotroph number in male but not female mice.

Authors:  J F Morris; S Omer; E Davies; E Wang; C John; T Afzal; S Wain; J C Buckingham; R J Flower; H C Christian
Journal:  J Neuroendocrinol       Date:  2006-11       Impact factor: 3.627

4.  Annexin A1 mimetic peptide controls the inflammatory and fibrotic effects of silica particles in mice.

Authors:  P G Trentin; T P T Ferreira; A C S Arantes; B T Ciambarella; R S B Cordeiro; R J Flower; M Perretti; M A Martins; P M R Silva
Journal:  Br J Pharmacol       Date:  2015-04-10       Impact factor: 8.739

5.  Green tea inhibits cycolooxygenase-2 in non-small cell lung cancer cells through the induction of Annexin-1.

Authors:  Qing-Yi Lu; Yusheng Jin; Jenny T Mao; Zuo-Feng Zhang; David Heber; Steven M Dubinett; Jianyu Rao
Journal:  Biochem Biophys Res Commun       Date:  2012-10-02       Impact factor: 3.575

6.  Overexpression of ANXA1 confers independent negative prognostic impact in rectal cancers receiving concurrent chemoradiotherapy.

Authors:  Ming-Jen Sheu; Chien-Feng Li; Ching-Yih Lin; Sung-Wei Lee; Li-Ching Lin; Tzu-Ju Chen; Li-Jung Ma
Journal:  Tumour Biol       Date:  2014-05-09

7.  Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasone.

Authors:  J A Mitchell; M G Belvisi; P Akarasereenont; R A Robbins; O J Kwon; J Croxtall; P J Barnes; J R Vane
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

8.  Up-regulation of Annexin-A1 and lipoxin A(4) in individuals with ulcerative colitis may promote mucosal homeostasis.

Authors:  Linda Vong; Jose G P Ferraz; Neil Dufton; Remo Panaccione; Paul L Beck; Philip M Sherman; Mauro Perretti; John L Wallace
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

9.  Expression and activation of erbB-2 and epidermal growth factor receptor in lung adenocarcinomas.

Authors:  W J Rachwal; P F Bongiorno; M B Orringer; R I Whyte; S P Ethier; D G Beer
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.